129 related articles for article (PubMed ID: 29027049)
1. Acute phase dynamics of circulating tumor cells after paclitaxel and doxorubicin chemotherapy in breast cancer mouse models.
Adachi Y; Yoshimura M; Nishida K; Usuki H; Shibata K; Hattori M; Kondo N; Yatabe Y; Iwata H; Kikumori T; Kodera Y; Nakanishi H
Breast Cancer Res Treat; 2018 Jan; 167(2):439-450. PubMed ID: 29027049
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of Circulating Tumor Cells Early After Targeting Therapy to Human
Ito A; Nakanishi H; Yoshimura M; Ito S; Sakao Y; Kodera Y; Yatabe Y; Kaneda N
Anticancer Res; 2019 Sep; 39(9):4711-4720. PubMed ID: 31519570
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort.
Jansson S; Bendahl PO; Larsson AM; Aaltonen KE; Rydén L
BMC Cancer; 2016 Jul; 16():433. PubMed ID: 27390845
[TBL] [Abstract][Full Text] [Related]
4. A rapid and quantitative method to detect human circulating tumor cells in a preclinical animal model.
Tu SH; Hsieh YC; Huang LC; Lin CY; Hsu KW; Hsieh WS; Chi WM; Lee CH
BMC Cancer; 2017 Jun; 17(1):440. PubMed ID: 28645267
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer.
Iwata H; Masuda N; Yamamoto D; Sagara Y; Sato N; Yamamoto Y; Saito M; Fujita T; Oura S; Watanabe J; Tsukabe M; Horiguchi K; Hattori S; Matsuura Y; Kuroi K
Breast Cancer Res Treat; 2017 Apr; 162(3):501-510. PubMed ID: 28181129
[TBL] [Abstract][Full Text] [Related]
6. ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic outcome of ovarian cancer.
Chebouti I; Kuhlmann JD; Buderath P; Weber S; Wimberger P; Bokeloh Y; Hauch S; Kimmig R; Kasimir-Bauer S
Oncotarget; 2017 Apr; 8(15):24303-24313. PubMed ID: 28388557
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor cells as predictors of response and failure in breast cancer patients treated with preoperative chemotherapy.
Boutrus RR; Abi Raad RF; Kuter I; Ancukiewicz M; Roberts L; Solomon N; Ngo T; Borick H; Ryan P; Moy B; Gadd M; Chien J; Younger J; Smith B; Taghian AG; Harris L
Int J Biol Markers; 2013 Apr; 28(1):17-23. PubMed ID: 23015398
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumor cells in patients with breast cancer: monitoring chemotherapy success.
Ušiaková Z; Mikulová V; Pintérová D; Brychta M; Valchář J; Kubecová M; Tesařová P; Bobek V; Kološtová K
In Vivo; 2014; 28(4):605-14. PubMed ID: 24982230
[TBL] [Abstract][Full Text] [Related]
9. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.
Mu Z; Wang C; Ye Z; Austin L; Civan J; Hyslop T; Palazzo JP; Jaslow R; Li B; Myers RE; Jiang J; Xing J; Yang H; Cristofanilli M
Breast Cancer Res Treat; 2015 Dec; 154(3):563-71. PubMed ID: 26573830
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
[TBL] [Abstract][Full Text] [Related]
11. Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer.
Botteri E; Sandri MT; Bagnardi V; Munzone E; Zorzino L; Rotmensz N; Casadio C; Cassatella MC; Esposito A; Curigliano G; Salvatici M; Verri E; Adamoli L; Goldhirsch A; Nolè F
Breast Cancer Res Treat; 2010 Jul; 122(1):211-7. PubMed ID: 19967556
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: a sub-study from the NeoALTTO phase III trial.
Azim HA; Rothé F; Aura CM; Bavington M; Maetens M; Rouas G; Gebhart G; Gamez C; Eidtmann H; Baselga J; Piccart-Gebhart M; Ellis C; Vuylsteke P; Cure H; Domont J; Ferro A; Toral-Peña JC; de Azambuja E; Sotiriou C; Di Cosimo S; Ignatiadis M
Breast; 2013 Dec; 22(6):1060-5. PubMed ID: 24060577
[TBL] [Abstract][Full Text] [Related]
13. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
[TBL] [Abstract][Full Text] [Related]
14. Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019.
Paoletti C; Li Y; Muñiz MC; Kidwell KM; Aung K; Thomas DG; Brown ME; Abramson VG; Irvin WJ; Lin NU; Liu MC; Nanda R; Nangia JR; Storniolo AM; Traina TA; Vaklavas C; Van Poznak CH; Wolff AC; Forero-Torres A; Hayes DF;
Clin Cancer Res; 2015 Jun; 21(12):2771-9. PubMed ID: 25779948
[TBL] [Abstract][Full Text] [Related]
15. Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer.
Yao J; Feng J; Gao X; Wei D; Kang T; Zhu Q; Jiang T; Wei X; Chen J
Biomaterials; 2017 Jan; 113():1-17. PubMed ID: 27794222
[TBL] [Abstract][Full Text] [Related]
16. Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy.
Mikulová V; Cabiňaková M; Janatková I; Mestek O; Zima T; Tesařová P
Scand J Clin Lab Invest; 2014 Mar; 74(2):132-42. PubMed ID: 24350991
[TBL] [Abstract][Full Text] [Related]
17. The effects of β-caryophyllene oxide and trans-nerolidol on the efficacy of doxorubicin in breast cancer cells and breast tumor-bearing mice.
Hanušová V; Caltová K; Svobodová H; Ambrož M; Skarka A; Murínová N; Králová V; Tomšík P; Skálová L
Biomed Pharmacother; 2017 Nov; 95():828-836. PubMed ID: 28903178
[TBL] [Abstract][Full Text] [Related]
18. [Identification of Circulating Tumor Cell（CTC）in Breast Cancer Patients Using a Newly Established CTC Detecting System].
Nagata T; Ohnaga T; Lu XL; Watanabe T; Hirano K; Okumura T; Tsukada K
Gan To Kagaku Ryoho; 2015 Oct; 42(10):1240-2. PubMed ID: 26489559
[TBL] [Abstract][Full Text] [Related]
19. Comparison of three different methods for the detection of circulating tumor cells in mice with lung metastasis.
Xu W; Wu B; Fu L; Chen J; Wang Z; Huang F; Chen J; Zhang M; Zhang Z; Lin J; Lan R; Chen R; Chen W; Chen L; Hong J; Zhang W; Ding Y; Okunieff P; Lin J; Zhang L
Oncol Rep; 2017 Jun; 37(6):3219-3226. PubMed ID: 28498481
[TBL] [Abstract][Full Text] [Related]
20. Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients.
Tokudome N; Ito Y; Takahashi S; Kobayashi K; Taira S; Tsutsumi C; Oto M; Oba M; Inoue K; Kuwayama A; Masumura K; Nakayama Y; Watanabe C; Hatake K
Breast Cancer; 2011 Jul; 18(3):195-202. PubMed ID: 21465230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
